Brooks Laboratories Ltd - 533543 - Board Meeting Intimation for Board Meeting To Be Held On 11.06.2019 For The Approval Of Rights Issue Of The Shares.
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/06/2019 ,inter alia, to consider and approve Rights Issue of the Equity Shares. Brooks Laboratories Ltd - 533543 - Newspaper Publication Of The Financials For The Quarter And Year Ended 31.03.2019
Newspaper publication of the financials for the quarter and year ended 31.03.2019 Brooks Laboratories Ltd - 533543 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report29/05/2019 3 Name of the Certifying Firm Sharma Sarin & Associates 4 Name of the Certifying Individual Mr. G.S.Sarin 5Membership TypeFCS 6 Membership Number 4025 7 CP No. 2751 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO Brooks Laboratories Ltd - 533543 - Audited Financial Results For The Financial Ended 31.03.2019
Audited Financial Results for the financial ended 31.03.2019 Brooks Laboratories Ltd - 533543 - Board Meeting Intimation for Annual Audited Financial Results For The Year Ended 31.03.2019
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2019 ,inter alia, to consider and approve Annual Audited Financial Results for the year ended 31.03.2019 Brooks Koepka in a world of his own at Bethpage Black
American opens a 9-shot lead with 63 on the first day of the PGA Championships BROOKS LABORATORIES LTD. - 533543 - Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996
Compliance Certificate under Reg 74(5) of SEBI(DP) Regulations, 2018 for the 4th quarter ended 31.03.2019 BROOKS LABORATORIES LTD. - 533543 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayBROOKS LABORATORIES LTD. 2CININE650L01011 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 16 4Highest Credit Rating during the previous FY BB+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Jyoti Sancheti Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Anil Kumar Pillai Designation: Chief Financial Officer EmailId: [email protected] Date: 23/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. BROOKS LABORATORIES LTD. - 533543 - PCS Certificate Under Reg 40(10) Of SEBI(LODR), Regulations, 2015 For The Half Year Ended 31.03.2019.
PCS Certificate under Reg 40(10) of SEBI(LODR), Regulations, 2015 for the half year ended 31.03.2019.